Header01-REBRAND_MENARINISILICONBIOSYSTEMS

 

Press Releases

11/30/2021

New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care


As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease

continue →

Topics: CELLSEARCH, Liquid biopsy, Multiple myeloma, CLIA Lab, LDT